Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2020
Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy
Laura A Sena, Hao Wang, Su J Lim ScM, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 19, 2024
Initial Experience with [<sup>177</sup>Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
Andrei Gafita, Andrew Voter, Somya Shesadri, et al.
European Urology
|
July 7, 2020
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts
Mark C Markowski, Hao Wang, Rana Sullivan, et al.
JCO Oncology Practice
|
February 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing
Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh, et al.
Journal of Neurosurgery. Spine
|
May 6, 2023
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis
Emerson Lee, Xuguang Chen, Michael C LeCompte, et al.
Frontiers in Oncology
|
September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma
Rajan Singh, Anand K Thotakura, Suresh Alati, et al.
Annals of Nuclear Medicine
|
March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging
Sara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
The Prostate
|
May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancer
Rudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
JCI Insight
|
November 16, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
Jiayu Chen, Qizhi Zheng, Jessica L Hicks, et al.
European Urology Oncology
|
December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
Mark C Markowski, Yi Ren, Meghan Tierney, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2020
Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy
Laura A Sena, Hao Wang, Su J Lim ScM, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 19, 2024
Initial Experience with [<sup>177</sup>Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
Andrei Gafita, Andrew Voter, Somya Shesadri, et al.
European Urology
|
July 7, 2020
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts
Mark C Markowski, Hao Wang, Rana Sullivan, et al.
JCO Oncology Practice
|
February 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing
Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh, et al.
Journal of Neurosurgery. Spine
|
May 6, 2023
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis
Emerson Lee, Xuguang Chen, Michael C LeCompte, et al.
Frontiers in Oncology
|
September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma
Rajan Singh, Anand K Thotakura, Suresh Alati, et al.
Annals of Nuclear Medicine
|
March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging
Sara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
The Prostate
|
May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancer
Rudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
JCI Insight
|
November 16, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression
Jiayu Chen, Qizhi Zheng, Jessica L Hicks, et al.
European Urology Oncology
|
December 12, 2024
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer
Mark C Markowski, Yi Ren, Meghan Tierney, et al.
Page
of 8